Articles by Mark J. Hall - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Mark J. Hall

Mark J. Hall

Mark J. Hall, is a lead application development specialist at Dow Wolff Cellulosics R&D, The Dow Chemical Company, 1691 N. Swede Road, Larkin Laboratory, Midland, MI 48674, tel. 989.636.4202, fax 989.638.9836.

A New Hypromellose Excipient for Direct Compression and Controlled Release
April 1, 2009

The authors examine the use of a hypromellose-based product as an excipient in a controlled release formulation using direct-compression tableting.

Hypromellose, Ethylcellulose, and Polyethylene Oxide Use in Hot Melt Extrusion
January 1, 2006

Hot melt extrusion (HME) formulation development depends heavily on choosing the appropriate polymers. This article reviews HME process parameters and highlights three polymers in HME: polyethylene oxide, ethylcellulose, and hypromellose.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here